Possible chemical mechanisms underlying the antitumor activity of S-deoxyleinamycin

Bioorganic & Medicinal Chemistry Letters
2008.0

Abstract

Though less potent than the parent natural product leinamycin, S-deoxyleinamycin displays activity against human cancer cell lines that is comparable to many clinically used agents. The results reported here suggest that the 1,2-dithiolan-3-one heterocycle found in S-deoxyleinamycin reacts with thiols to generate a persulfide intermediate (RSS(-)) that could deliver biologically active polysulfides, hydrogen sulfide, and reactive oxygen species (O2*-, H(2)O(2), and HO*) to the interior of cells.

Knowledge Graph

Similar Paper

Possible chemical mechanisms underlying the antitumor activity of S-deoxyleinamycin
Bioorganic & Medicinal Chemistry Letters 2008.0
Synthesis and characterization of a small analogue of the anticancer natural product leinamycin
Bioorganic & Medicinal Chemistry 2013.0
The macrocycle of leinamycin imparts hydrolytic stability to the thiol-sensing 1,2-dithiolan-3-one 1-oxide unit of the natural product
Bioorganic & Medicinal Chemistry Letters 2012.0
Synthesis and evaluation of 8,4′-dideshydroxy-leinamycin revealing new insights into the structure–activity relationship of the anticancer natural product leinamycin
Bioorganic & Medicinal Chemistry Letters 2015.0
Synthesis and Cytotoxicity of Leinamycin Antibiotic Analogues
Journal of Medicinal Chemistry 2006.0
Synthesis and Antitumor Activity of Novel Thioester Derivatives of Leinamycin
Journal of Medicinal Chemistry 1999.0
Improved synthesis of deoxyalpinoid B and quantification of antileishmanial activity of deoxyalpinoid B and sulforaphane
Bioorganic & Medicinal Chemistry 2023.0
Design and synthesis of an antitumor prodrug released by the reaction with sulfhydryl compounds
Bioorganic & Medicinal Chemistry Letters 1995.0
Synthesis, DNA intercalation and 3D QSAR analysis of cis-2,4,5-trisubstituted-1,3-dithiolanes as a novel class of antitumor agents
Bioorganic & Medicinal Chemistry 2009.0
Antitumor Activity of Novel Deoxoartemisinin Monomers, Dimers, and Trimer
Journal of Medicinal Chemistry 2003.0